X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (8516) 8516
Publication (616) 616
Book Review (100) 100
Book Chapter (93) 93
Book / eBook (58) 58
Newsletter (23) 23
Web Resource (13) 13
Conference Proceeding (5) 5
Magazine Article (5) 5
Journal / eJournal (2) 2
Dissertation (1) 1
Newspaper Article (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (7084) 7084
male (3545) 3545
female (3265) 3265
index medicus (3228) 3228
middle aged (2384) 2384
adult (2372) 2372
lymphoproliferative disorders (2204) 2204
transplantation (1904) 1904
hematology (1866) 1866
aged (1590) 1590
oncology (1580) 1580
child (1294) 1294
lymphoproliferative disorders - etiology (1268) 1268
immunology (1211) 1211
epstein-barr virus (1196) 1196
adolescent (1177) 1177
lymphoma (1169) 1169
epstein-barr-virus (1153) 1153
disease (1071) 1071
lymphomas (984) 984
surgery (910) 910
risk factors (903) 903
lymphoproliferative disorders - pathology (866) 866
child, preschool (842) 842
pathology (823) 823
therapy (822) 822
immunosuppression (819) 819
lymphoproliferative disorders - therapy (819) 819
treatment outcome (819) 819
cancer (796) 796
lymphoproliferative disorders - diagnosis (764) 764
health aspects (756) 756
lymphoproliferative disorders - virology (746) 746
lymphoproliferative disorders - drug therapy (745) 745
retrospective studies (743) 743
rituximab (739) 739
lymphoproliferative disorders - immunology (723) 723
animals (710) 710
diagnosis (679) 679
pediatrics (663) 663
recipients (663) 663
prognosis (642) 642
lymphocytes (608) 608
infant (600) 600
care and treatment (599) 599
immunosuppressive agents - therapeutic use (594) 594
infection (580) 580
epstein-barr virus infections - complications (564) 564
aged, 80 and over (520) 520
lymphoproliferative disorder (520) 520
children (517) 517
chemotherapy (511) 511
immunotherapy (505) 505
leukemia (501) 501
lymphoproliferative disorders - complications (501) 501
diagnosis, differential (492) 492
immunosuppressive agents - adverse effects (489) 489
non-hodgkins-lymphoma (485) 485
herpesvirus 4, human - isolation & purification (483) 483
hemic and lymphatic diseases (479) 479
research (477) 477
t cells (477) 477
posttransplant lymphoproliferative disorder (470) 470
risk (468) 468
lymphoproliferative disease (459) 459
medicine & public health (455) 455
expression (452) 452
posttransplant lymphoproliferative disorders (429) 429
young adult (429) 429
lymphoproliferative disorders - genetics (424) 424
analysis (415) 415
biopsy (412) 412
follow-up studies (411) 411
time factors (393) 393
kidney transplantation - adverse effects (386) 386
ebv (385) 385
immunohistochemistry (383) 383
antineoplastic agents - therapeutic use (381) 381
herpesvirus 4, human - genetics (378) 378
kidney transplantation (368) 368
incidence (364) 364
antibodies, monoclonal - therapeutic use (362) 362
antineoplastic combined chemotherapy protocols - therapeutic use (359) 359
bone-marrow-transplantation (359) 359
dermatology (356) 356
disorders (355) 355
herpesvirus 4, human (350) 350
apoptosis (346) 346
stem-cell transplantation (346) 346
chronic lymphocytic-leukemia (342) 342
transplantation, homologous (342) 342
medicine, general & internal (341) 341
polymerase chain reaction (339) 339
lymphoproliferative disorders - epidemiology (328) 328
tumors (328) 328
viral load (322) 322
mice (321) 321
epstein-barr virus infections - virology (319) 319
stem cells (317) 317
epstein–barr virus (312) 312
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (8188) 8188
French (113) 113
Japanese (99) 99
German (73) 73
Spanish (64) 64
Russian (43) 43
Polish (26) 26
Italian (24) 24
Chinese (17) 17
Korean (14) 14
Hungarian (9) 9
Portuguese (6) 6
Czech (4) 4
Dutch (4) 4
Hebrew (4) 4
Turkish (4) 4
Croatian (3) 3
Danish (3) 3
Finnish (2) 2
Norwegian (1) 1
Romanian (1) 1
Slovak (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
American Journal of Transplantation, ISSN 1600-6135, 02/2011, Volume 11, Issue 2, pp. 336 - 347
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 01/2013, Volume 31, Issue 1, pp. 39 - 48
Journal Article
Journal Article
American Journal of Surgical Pathology, ISSN 0147-5185, 03/2010, Volume 34, Issue 3, pp. 405 - 417
We describe a series of Epstein Barr virus (EBV)-positive circumscribed, ulcerative lesions associated with various types of immunosuppression (IS). The study... 
Immunosuppression | Lymphoprolifeative | Epstein Barr virus | Mucocutaneous | SURGERY | CELL LYMPHOPROLIFERATIVE DISORDERS | OPTIMAL PRIMER SELECTION | NON-HODGKINS-LYMPHOMAS | immunosuppression | lymphoproliferative | PERIPHERAL-BLOOD | PATHOLOGY | CD8(+) T-CELLS | LYMPHOCYTE SUBPOPULATIONS | mucocutaneous | CYTOMEGALOVIRUS SEROPOSITIVITY | CHAIN-REACTION ANALYSIS | ELDERLY-PATIENTS | EPSTEIN-BARR-VIRUS | Immunohistochemistry | Recurrence | Humans | Middle Aged | Lymphoproliferative Disorders - chemically induced | Male | Skin Ulcer - immunology | Gastrointestinal Diseases - virology | T-Lymphocytes - virology | Epstein-Barr Virus Infections - etiology | Epstein-Barr Virus Infections - therapy | T-Lymphocytes - drug effects | Aged, 80 and over | B-Lymphocytes - virology | Gastrointestinal Diseases - pathology | Skin Diseases, Infectious - virology | Skin Diseases, Infectious - pathology | Mouth Mucosa - immunology | Immune Tolerance | Gastrointestinal Diseases - therapy | Lymphoproliferative Disorders - pathology | Epstein-Barr Virus Infections - pathology | B-Lymphocytes - immunology | Mouth Mucosa - virology | Remission, Spontaneous | T-Lymphocytes - immunology | Oral Ulcer - pathology | Skin Diseases, Infectious - immunology | Age Factors | Oral Ulcer - immunology | Lymphoproliferative Disorders - immunology | Lymphoproliferative Disorders - therapy | Oral Ulcer - chemically induced | Mouth Mucosa - drug effects | In Situ Hybridization | Epstein-Barr Virus Infections - chemically induced | Polymerase Chain Reaction | Adult | Female | Skin Ulcer - virology | Skin Diseases, Infectious - therapy | Gastrointestinal Diseases - immunology | Skin Ulcer - therapy | Epstein-Barr Virus Infections - immunology | Gene Rearrangement, T-Lymphocyte | Lymphoproliferative Disorders - virology | Skin Diseases, Infectious - chemically induced | Treatment Outcome | Skin Ulcer - chemically induced | Genes, Immunoglobulin | B-Lymphocytes - drug effects | Oral Ulcer - therapy | Skin Ulcer - pathology | Immunosuppressive Agents - adverse effects | Aged | Oral Ulcer - virology | Gastrointestinal Diseases - chemically induced | Muco-cutaneous | Lymphoproliferative
Journal Article
British Journal of Haematology, ISSN 0007-1048, 11/2014, Volume 167, Issue 3, pp. 402 - 410
Summary Epstein‐Barr virus (EBV) is associated with several malignancies, including post‐transplant lymphoproliferative disorder (PTLD). Conventional... 
lymphoproliferative disease | cell therapy | cytotoxicity | Epstein‐Barr virus | Cytotoxicity | Lymphoproliferative disease | Epstein-Barr virus | Cell therapy | MULTICENTER | INFECTIONS | DISORDERS | RECIPIENTS | THERAPY | LYMPHOMA | MARROW-TRANSPLANTATION | HEMATOLOGY | T-CELLS | ADOPTIVE IMMUNOTHERAPY | LYMPHOCYTES | Leiomyosarcoma - virology | Humans | Middle Aged | Child, Preschool | Infant | Male | Lymphoproliferative Disorders - immunology | Tissue Banks - standards | Postoperative Complications - immunology | Sarcoma - therapy | Sarcoma - virology | Lymphoproliferative Disorders - therapy | Young Adult | Postoperative Complications - virology | Allografts | T-Lymphocytes, Cytotoxic - transplantation | Epstein-Barr Virus Infections - therapy | Tissue Banks - organization & administration | Female | Lymphoproliferative Disorders - etiology | T-Lymphocytes, Cytotoxic - immunology | Central Nervous System Neoplasms - virology | Immunotherapy, Adoptive | Histocompatibility Testing | Epstein-Barr Virus Infections - immunology | Lymphoproliferative Disorders - virology | Herpesvirus 4, Human - immunology | Central Nervous System Neoplasms - therapy | Postoperative Complications - therapy | Treatment Outcome | Lung Neoplasms - therapy | Lung Neoplasms - virology | Remission Induction | Leiomyosarcoma - therapy | New Zealand | HLA Antigens - analysis | Licensure | Adolescent | T-Cell Antigen Receptor Specificity | Banks (Finance) | Transplantation
Journal Article
by Coulter, Tanya I., MRCPI and Chandra, Anita, PhD, FRCPath and Bacon, Chris M., PhD, FRCPath and Babar, Judith, MRCP, FRCR and Curtis, James, PhD and Screaton, Nick, FRCP, FRCR and Goodlad, John R., MD, FRCPath and Farmer, George, MD and Steele, Cathal Laurence, MB and Leahy, Timothy Ronan, MRCPI and Doffinger, Rainer, PhD, FRCPath and Baxendale, Helen, PhD, FRCPath and Bernatoniene, Jolanta, PhD and Edgar, J. David M., FRCP, FRCPath and Longhurst, Hilary J., PhD, FRCPath and Ehl, Stephan, MD, PhD and Speckmann, Carsten, MD and Grimbacher, Bodo, MD, PhD and Sediva, Anna, MD, PhD and Milota, Tomas, MD and Faust, Saul N., PhD, FRCPCH and Williams, Anthony P., PhD, FRCPath and Hayman, Grant, FRCP, FRCPath and Kucuk, Zeynep Yesim, MD and Hague, Rosie, MRCP, FRCPH and French, Paul, MD, MRCS, DipFMS, FRCPath and Brooker, Richard, FRCPCH and Forsyth, Peter, FRCPath and Herriot, Richard, FRCP, FRCPath and Cancrini, Caterina, MD, PhD and Palma, Paolo, MD, PhD and Ariganello, Paola, MD and Conlon, Niall, PhD, FRCPath and Feighery, Conleth, PhD, FRCPath and Gavin, Patrick J., MD and Jones, Alison, PhD, FRCPCH and Imai, Kohsuke, MD, PhD and Ibrahim, Mohammad A.A., PhD, FRCP, FRCPath and Markelj, Gašper, MD and Abinun, Mario, MD, PhD and Rieux-Laucat, Frédéric, PhD and Latour, Sylvain, PhD and Pellier, Isabelle, MD, PhD and Fischer, Alain, MD, PhD and Touzot, Fabien, MD, PhD and Casanova, Jean-Laurent, MD, PhD and Durandy, Anne, MD, PhD and Burns, Siobhan O., MD, PhD and Savic, Sinisa, PhD, FRCPath and Kumararatne, D.S., FRCPath, DPhil (Oxon) and Moshous, Despina, MD, PhD and Kracker, Sven, PhD and Vanhaesebroeck, Bart, PhD, FMedSci and Okkenhaug, Klaus, PhD and Picard, Capucine, MD, PhD and Nejentsev, Sergey, MD, PhD and Condliffe, Alison M., PhD, FRCP and Cant, Andrew James, MD, FRCP, FRCPH
Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2016, Volume 139, Issue 2, pp. 597 - 606.e4
Background Activated phosphoinositide 3-kinase δ syndrome (APDS) is a recently described combined immunodeficiency resulting from gain-of-function mutations in... 
Allergy and Immunology | Activated phosphoinositide 3-kinase δ syndrome | hematopoietic stem cell transplantation | phosphoinositide 3-kinase δ | immunodeficiency | phosphoinositide 3-kinase inhibitor | PIK3CD gene | bronchiectasis | p110δ-activating mutation causing senescent T cells, lymphadenopathy, and immunodeficiency | Recurrence | Humans | Middle Aged | Child, Preschool | Infant | Male | Antibiotic Prophylaxis | Class I Phosphatidylinositol 3-Kinases/antagonists & inhibitors | Young Adult | Immunoglobulins, Intravenous/therapeutic use | Enzyme Inhibitors/therapeutic use | Lymphoproliferative Disorders/genetics | Adult | Female | Surveys and Questionnaires | Child | Respiratory Tract Infections/genetics | Mutation/genetics | Hematopoietic Stem Cell Transplantation | International Cooperation | Herpesviridae Infections/genetics | Animals | Adolescent | Survival Analysis | Mice | Immunologic Deficiency Syndromes/genetics | Cohort Studies | Activated phosphoinositide 3-kinase delta syndrome | IMMUNOLOGICAL FEATURES | HYPER-IGM SYNDROME | p110 delta-activating mutation causing senescent T cells | hematopoietic stem cell | COMMON VARIABLE IMMUNODEFICIENCY | PIK3CD | IMMUNOLOGY | lymphadenopathy | REFERENCE VALUES | P110-DELTA | phosphoinositide 3-kinase delta | P110 DELTA | B-CELL | ALLERGY | transplantation | MUTATIONS | Class I Phosphatidylinositol 3-Kinases - genetics | Herpesviridae Infections - mortality | Respiratory Tract Infections - genetics | Lymphoproliferative Disorders - therapy | Respiratory Tract Infections - mortality | Respiratory Tract Infections - therapy | Immunologic Deficiency Syndromes - mortality | Herpesviridae Infections - genetics | Immunologic Deficiency Syndromes - therapy | Lymphoproliferative Disorders - genetics | Mutation - genetics | Class I Phosphatidylinositol 3-Kinases - antagonists & inhibitors | Enzyme Inhibitors - therapeutic use | Lymphoproliferative Disorders - mortality | Herpesviridae Infections - therapy | Immunoglobulins, Intravenous - therapeutic use | Immunologic Deficiency Syndromes - genetics | Immune Deficiencies, Infection, and Systemic Immune Disorders | HSCT, Hematopoietic stem cell transplantation | BALF, Bronchoalveolar lavage fluid | CT, Computed tomography | APDS, Activated phosphoinositide-3 kinase δ syndrome | GOF, Gain of function | PI3K, Phosphoinositide 3-kinase | HSV, Herpes simplex virus | CMV, Cytomegalovirus | OR, Odds ratio | PPV, Pneumococcal polysaccharide vaccine | CNS, Central nervous system
Journal Article
Blood, ISSN 0006-4971, 02/2010, Volume 115, Issue 5, pp. 925 - 935
Journal Article
Journal Article
The American Journal of Surgical Pathology, ISSN 0147-5185, 11/2014, Volume 38, Issue 11, pp. 1522 - 1529
Journal Article
British Journal of Haematology, ISSN 0007-1048, 06/2010, Volume 149, Issue 5, pp. 693 - 705
Journal Article